DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Tabernero JM, van Cutsem E, Sastre J. et al.
An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results.
JCO 2004; 22: 3512-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.